February 12, 2016

Health Update

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.


As I mentioned a couple of weeks ago, my chemo regimen changed last month. The Revlimid reduced my M-protein level for a little while, but then flattened out around 0.6, which is still a long way from zero.1 So now we’re trying Revlimid plus dexamethasone. Dex is pure evil, but it’s also pretty good at fighting multiple myeloma, so let’s all give a big round of applause to evil! My first test result came back yesterday, and after only three weeks on the dex my M-protein marker has finally budged from 0.6. It’s now down to 0.48. There’s still a long way to go, but at least things are once again moving in the right direction.

1Standard explainer: myeloma cells produce M-proteins, so measuring them is a good proxy for the level of cancerous cells in my bone marrow. This will never get to zero, but when the M-protein marker reaches zero it means the myeloma is at a very, very low level. So that’s the goal.

DECEMBER IS MAKE OR BREAK

A full one-third of our annual fundraising comes in this month alone. That’s risky, because a strong December means our newsroom is on the beat and reporting at full strength—but a weak one means budget cuts and hard choices ahead.

With only days left until December 31, we've raised about half of our $400,000 goal—but we need a huge surge in reader support to close the remaining gap. Whether you've given before or this is your first time, your contribution right now matters.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do. That’s why we need you right now. Please chip in to help close the gap.

DECEMBER IS MAKE OR BREAK

A full one-third of our annual fundraising comes in this month alone. That’s risky, because a strong December means our newsroom is on the beat and reporting at full strength—but a weak one means budget cuts and hard choices ahead.

With only days left until December 31, we've raised about half of our $400,000 goal—but we need a huge surge in reader support to close the remaining gap. Whether you've given before or this is your first time, your contribution right now matters.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do. That’s why we need you right now. Please chip in to help close the gap.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate